Загрузка...
Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson’s disease
Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on chronic levodopa therapy. The management of LID is important as dyskinesia can be disabling and impair quality of life. Currently, there are limited treatment options for the medical management o...
Сохранить в:
| Опубликовано в: : | Ther Clin Risk Manag |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905495/ https://ncbi.nlm.nih.gov/pubmed/29695911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S144481 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|